Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of January 23, 2022
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Natural protection from COVID-19 gets boost from a single dose of vaccine
Tests of patients' blood show vaccine stirs antibodies against variants and 2003 SARS virus
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
Scientists map structure of potent antibody against coronavirus
Computer-generated images show why immune protein neutralizes SARS-CoV-2
Antibodies a hot topic in COVID-19 research
Hutch scientists tap their antibody expertise for new tests, treatments, vaccines
Antibody blocks Epstein-Barr virus in preclinical trial
Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Clues from coronavirus’ past
From the University of Washington and the McGuire lab, Vaccine and Infectious Disease Division
New research projects aim to advance COVID-19 testing, treatment
Projects by Drs. Keith Jerome, Andrew McGuire funded by $350,000 gift from M.J. Murdock Charitable Trust
Hutch team hunts for coronavirus antibodies
Screening blood from survivors to find immune proteins for treatments and guide vaccine research
Baiting for B cells: A clever new way to make an AIDS vaccine
Researchers fish for rare blood cells that can evolve into HIV blockers
Creating antibodies with antibodies
From the McGuire, Taylor, and Stamatatos labs, Vaccine and Infectious Disease Division
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Double trouble: epithelial and B cell neutralization of Epstein-Barr virus
McGuire Laboratory, Vaccine and Infectious Disease Division
First human antibody found to block Epstein-Barr virus
Early research could open new path for vaccine against EBV-related cancers, mononucleosis
Jump-starting innovative projects exploring pathogen-associated cancers
Pathogen-Associated Malignancies Integrated Research Center awards first round of pilot funding supporting researchers studying H. pylori, EBV and the microbiome
Closing in on ‘holy grail’ of HIV vaccine
Researchers describe a way to induce long-sought broadly neutralizing antibodies